In a synthetic audience simulation conducted by Minds, 310 Swiss executives evaluated preventative cardiology diagnostic packages within Swiss medical spas. Against the backdrop of official data on private healthcare spending from the Bundesamt für Statistik, the findings show that 74 percent of affluent professionals and leaders prioritize evidence-based cardiovascular screenings over purely wellness-focused services and are willing to fund them out of pocket.
74%
Priority for cardiology over wellness
68%
Willingness to pay out-of-pocket
61%
Skepticism toward unclear evidence
Based on a simulated Audience of 310 respondent. Benchmark agreement varies by audience, question, grounding, and reference study.
Audience composition
Age Groups
1
45-52 years38%
2
53-60 years42%
3
61-68 years20%
Executive Profile
1
C-Level & Board Members45%
2
Private Equity & Finance35%
3
Entrepreneurs & Family Office20%
Kosten und Finanzierung des Gesundheitswesens
OECD Health Statistics: Health expenditure and financing
This study is based on an audience simulation calibrated precisely via silicon sampling to the segment of high-income Swiss executives aged 45 to 68. Each mind draws its reasoning logic from Minds PRISM, the proprietary reasoning, inference, and source-modeling engine powering Minds. Minds operates as an end-to-end platform for commercial synthetic research, unifying qualitative and quantitative methodologies within a single closed workflow.
Layered above the core architecture of Minds PRISM is an adaptive interaction engine spanning open-ended text surveys, rating scales, and multiple-choice questions through to forced-choice trade-off models such as MaxDiff. This enables innovation, strategy, and marketing teams to evaluate complex stimuli, such as pitch decks, websites, app flows, or Figma prototypes, wherever configured for the specific workspace.
The resulting data delivers directional, context-rich guidance for strategic decision-making ahead of physical pilot rollouts. Minds serves as a simulation infrastructure for commercial inquiries, not as a replacement for clinical regulatory trials, mandated medical evidence, or representative price elasticity studies. Specific data privacy and deployment requirements must always be evaluated at the individual customer workspace level.
A clear paradigm shift is unfolding across the Swiss market for premium health and regeneration services. Where passive relaxation concepts and vague anti-aging rituals once dominated, high-net-worth executives now demand rigorous medical diagnostics. Cardiology screenings play a central role here, as cardiovascular risks are perceived as the single greatest threat to personal performance and longevity.
The simulation reveals that 74 percent of surveyed minds clearly prioritize cardiovascular diagnostic packages over conventional spa and wellness packages. An institution's credibility is measured primarily by its clinical infrastructure and medical staffing: high-resolution coronary CT angiography, stress cardiac MRI, and specialized biomarker panels (such as ApoB, Lp(a), and high-sensitivity troponin) are viewed as the baseline standard for a premier institution.
B
Beatrix von Burg, 54, ZürichManaging Partner Private Equity
When I visit a Swiss clinic for cardiovascular screening, I expect university-level clinical precision, not vague longevity magic with a champagne markup.
This demographic is acutely sensitive to any blending of serious clinical medicine with esoteric lifestyle trends. As soon as marketing messaging pairs cardiovascular prevention with unsubstantiated wellness terminology, perceived credibility drops sharply. In fact, 61 percent of simulated minds express skepticism when facilities promote longevity claims without grounding them in recognized cardiology guidelines.
A key differentiator of this study lies in analyzing the psychological willingness to pay for cutting-edge diagnostics without reimbursement from mandatory health insurance (OKP). In Switzerland, the share of private out-of-pocket healthcare spending is traditionally high by international standards. According to data from the Bundesamt für Statistik and the OECD, Swiss households finance a substantial portion of their medical expenses directly out of pocket.
Among affluent C-level executives, private equity partners, and family office decision-makers, price rarely serves as the primary obstacle. Fully 68 percent of respondents demonstrate a pronounced willingness to pay five-figure sums entirely out of pocket for comprehensive diagnostic stays, provided the clinical value add significantly exceeds routine outpatient care.
D
Dr. Florian Meier, 49, BaselSenior Director Pharma
Preventative imaging and calcium scoring are essential for me. I am happy to pay out of pocket, provided the findings are interpreted by recognized cardiology specialists.
For this client segment, financial outlay is not viewed as a cost, but rather as a rational investment in personal human capital and risk mitigation. However, conversion hinges directly on how the offering is framed:
Transparent presentation of diagnostic scope with no hidden additional fees
Seamless integration of cardiovascular prevention, metabolic analytics, and individualized strain management
Specialist medical follow-up providing actionable, data-backed recommendations rather than generic lifestyle advice
Despite strong willingness to pay and high health awareness, many current offerings fall short due to specific points of friction highlighted in the simulation's qualitative findings. Time investment and institutional bureaucracy represent the primary barriers for C-level leaders.
Traditional hospital-based check-ups are frequently perceived as fragmented, time-consuming, and impersonal. Swiss medical spas hold a structural competitive advantage here, provided they can deliver the entire diagnostic pathway within a compact, seamless 48- to 72-hour stay.
M
Marc-André Gerber, 58, ZugFamily Office Executive
Time is my limiting factor. A modular diagnostic weekend with CT angiography and stress MRI delivers clear ROI for me, as long as the process is organized seamlessly in a discreet setting.
The following friction points were voiced with particular frequency across the panel:
Time lost due to waiting intervals between individual diagnostic modules
Lack of data sovereignty and concerns regarding the confidentiality of sensitive health records
Insufficient synthesis of findings: isolated cardiology results delivered without integration into a holistic preventative plan
Medical spas that pair diagnostic excellence with the discretion of a luxury hotel and strict time efficiency achieve significantly higher acceptance ratings in the simulation than traditional hospital-affiliated check-up centers.
The simulation findings translate into actionable recommendations for positioning and product development within Swiss health tourism:
Lead with clinical differentiation: Positioning must be anchored by chief physicians and recognized cardiologists. Co-branding with university institutes or leading heart centers measurably strengthens resonance among discerning executives.
Develop modular diagnostic packages: Audience-tailored packages require distinct focus profiles, such as an Executive Heart Shield or Advanced Coronary Screening, combining all imaging and laboratory procedures within a fixed time window.
Adopt evidence-based marketing language: Marketing leads should avoid hyperbolic longevity claims. Factual, evidence-backed, and methodically transparent service descriptions engage Swiss top decision-makers far more effectively.
Researching affluent niche demographics such as Swiss C-level executives presents immense challenges for conventional market research: high drop-out rates, costly participant recruitment, and lengthy field phases routinely slow down innovation cycles across clinics and wellness resorts.
Minds enables marketing, innovation, and insights teams to test new service concepts, pricing architectures, value claims, and landing pages beforehand using realistic audience simulations. Hypotheses surrounding the acceptance of cardiology screening packages can be sharpened iteratively in hours, eliminating the risk of misallocating budget to ineffective campaigns or premature market rollouts.
How robust are synthetic audience simulations for the Swiss luxury health segment?
Minds provides directional synthetic evidence to iteratively evaluate positioning, service bundles, and value propositions before conducting physical field tests.
How does Minds PRISM model complex decision patterns among affluent target groups?
The Minds PRISM engine models rigorous cognitive profiles by unifying domain expertise and methodological research designs within a consistent simulation environment.
How does this approach differ from traditional panel surveys in Switzerland?
Instead of months of recruitment and high per-respondent costs for hard-to-reach C-level audiences, Minds enables rapid qualitative and quantitative iterations without participant acquisition costs.
How can medical spas use these findings for service design?
Clinics can calibrate value propositions and screening concepts specifically around evidence and time efficiency before allocating marketing budgets to campaigns or brochures.
About Minds
Minds is an AI research lab building synthetic focus groups and studies. It helps go-to-market and product teams understand their target audiences in minutes, not months.
